News
Apotek Hjärtat starts preparation for possible listing on the Stockholm Stock Exchange

For more information, visit http://www.mynewsdesk.com/se/apotek-hjartat/pressreleases/apotek-hjaertat-startar-foerberedelser-foer-en-notering-paa-nasdaq-omx-stockholm-1012251

This notice does not constitute the offer of any securities for sale in any jurisdiction. The information contained in the linked pages does not form a part of Altor’s website.

Author: Katarina Karlsson
Date: 2014.06.25
Categories: News

Ulrika Werdelin new Board Member of Altor Funds

Altor was founded in 2003 and since inception, the Altor Funds have invested in close to 40 companies. Altor Funds today consist of three funds with a committed capital of EUR 3,800 million. Denis Viet-Jacobsen was one of the founders of Altor and has been on the Board of Directors of the three Altor Funds...

Altor completes successful fundraising for Fund IV

Altor has in record time closed its fourth fund, Altor Fund IV, at its target and hard cap of EUR 2,000 million, with significant additional interest from investors. Altor maintains its focus on developing mid-market companies in the Nordic region. The fund will be domiciled in Stockholm, Sweden. The vast majority of the capital has...